| Line item | 2025-09-30 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2024-06-30 FY | 2024-03-31 FY | 2023-12-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $13.06M | $3.67M | $2.63M | $2.34M | $7.03M | $1.84M | $1.60M | $1.51M |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | $5.31B | $708.97M | $1.90B | -$71.00M | $2.42B | $370.02M | $473.98M | $582.05M |
| EPS (basic) | 25.0600 | 3.1300 | 10.0500 | -0.4000 | 15.1900 | 2.3100 | 3.0300 | 3.8100 |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – | – |